Clinical trial
Bone Marrow Transplant From Related Donor for Patients With High Risk…
NCT00040469 · Baylor College of Medicine, Other · Terminated
Key facts
| NCT number | NCT00040469 |
|---|---|
| Title | Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies |
| Official title | Allogeneic Bone Marrow Transplant From HLA Identical Related Donors for Patients With High Risk Hemoglobinopathies: Hemoglobin SS, Hemoglobin SC, Hemoglobin SB0/+ Thalassemia, or Homozygous B0/+ Thalassemia or Severe Variants of B0/+ Thalassemia |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | The Methodist Hospital Research Institute Center for Cell and Gene Therapy, Baylor College of Medicine |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sickle Cell Anemia, Hemoglobinopathy, Thalassemia |
| Intervention type | Drug |
| Interventions | Campath -1H, Dilantin, Busulfan, Cyclophosphamide |
| Enrollment | 15 |
| Start date | Aug 1, 2000 |
| Primary completion | Nov 21, 2003 |
| Completion | Nov 21, 2003 |
| First posted | Jun 28, 2002 |
| Last update posted | Jan 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: